CTXR · Citius Pharmaceuticals, Inc. · Held by Funds
Substantial doubt about the company's ability to continue as a going concern.
“The Company estimates that its and Citius Oncology's collective available cash resources will be sufficient to fund our operations through November 2026. We will need to raise additional capital in the future to support our operations beyond November 2026, which raises substantial doubt about the Company's ability to continue as a going concern within one year after the date that the accompanying consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of CTXR by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 1.29% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 0.68% | 186,108 |
| Index ETFs | 0.61% | 167,738 |
| Active ETFs | 0.00% | 0 |
| Active funds | 0.00% | 0 |
| Unclassified | 0.00% | 0 |
| All registered funds | 1.29% | 353,846 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding CTXR
6 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | — | 167,738 | $101,398 | 0.00% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 165,178 | $95,836 | 0.00% | Long | 2026-08-31 | |
| Direxion Low Priced Stock ETF | — | 22,936 | $20,482 | 1.41% | Long | 2022-07-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 26,359 | $15,293 | 0.00% | Long | 2026-08-31 | |
| Fidelity Total Market Index Fund | FSKAX | 15,291 | $8,872 | 0.00% | Long | 2026-08-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 1,862 | $1,126 | 0.00% | Short | 2026-06-30 |